Učitavanje...

Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer

Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Matthew G. Field, H. Culver Boldt, Taher Abu Hejleh, Elaine M. Binkley
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2022-06-01
Serija:American Journal of Ophthalmology Case Reports
Teme:
Online pristup:http://www.sciencedirect.com/science/article/pii/S2451993622002055
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!